4//SEC Filing
LORANGER STEVEN R 4
Accession 0001225208-21-007756
CIK 0001099800other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 6:31 PM ET
Size
8.1 KB
Accession
0001225208-21-007756
Insider Transaction Report
Form 4
LORANGER STEVEN R
Director
Transactions
- Award
Common Stock
2021-05-05+2,615→ 49,580 total - Award
Director Stock Option (Right to Acquire)
2021-05-05+3,270→ 3,270 totalExercise: $91.77From: 2021-05-05Exp: 2028-05-04→ Common Stock (3,270 underlying)
Holdings
- 15,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These restricted stock units were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on the Issuer's Board.
- [F2]These options were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001226924
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 6:31 PM ET
- Size
- 8.1 KB